About this trial
the objective of this study is to determine the incidence of peri-implant mucositis in patients with treated periodontitis and enrolled in periodontal maintenance and to evaluate the associated risk indicators. An analytical prospective observational study will be carried out, with an initial follow-up of 12 months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Over 18 years of age, able to comply with the protocol and comply with the established visits.
Patients with treated periodontitis and enrolled in periodontal maintenance (last maintenance therapy received between 4 and 6 months maximum before inclusion in the study) (Chapple et al., 2018, Sanz et al., 2020).
Patients with osseointegrated dental implants waiting for their prosthodontic rehabilitation (fixed prosthesis [individual, partial or complete], hybrid or overdenture).
Physical or mental conditions that make it possible to perform appropiate oral hygiene
Disqualifiers
Patients with untreated periodontitis.
Totally edentulous patients.
Patients with peri-implant diseases.
Pregnant or in lactating-period patients.
Trial population
Patients with treated periodontitis who have had dental implants placed at the Periodontics Specialist Clinic of the UCM School of Dentistry, and are going to be rehabilitated in the same center
Trial design
Cohort
Prospective
Treatments tested in this trial
Supportive periodontal and periimplant care
Other interventionPeriodontal and peri-implant maintenance therapy will be carried out at baseline, 3 and 6-month visit. This session will include the removal of biofilm and calculus on teeth and implants (except those that have just been restored) with an ultrasonic device using a plastic tip ( for implants. and a conventional metal tip ( for teeth. At the end, polishing will be done with a rubber cup Subsequently, patients will be explained that they must continue with their usual oral hygiene technique on their teeth, using the same type of brush (which can be electric or manual), interproximal devices, toothpaste or mouthwash used to date. Finally, they will receive specific instructions for the supragingival biofilm control in the area of the new restoration and will be given interdental brushes that suit to the space
Treatment groups
Trial outcomes
Primary outcomes
Incidence of peri-implant mucositis
The risk of developing PM (patient with at least one implant who has bleeding on probing, with or without suppuration and without progressive radiographic bone loss) during a follow-up period of 12 months.
Secondary outcomes
Affiliation data
Age, Sex
previous medical history
systemic diseases, medication, allergies
smoking habit
ex-smoker/smoker/non-smoker
Other general data
sports habit, educational level, alcohol and coffee consumption, type of diet.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidad Complutense de Madrid
Lead sponsor
Sociedad Española de Periodoncia (SEPA)
Collaborator
Dentaid SL
Collaborator